On the other hand, Birtalana et al. [21] concluded that PD-L1 expression on immune cells indicates better prognosis in laryngeal squamous cell carcinoma and in HPV-negative head and neck squamous cell carcinoma. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.